Core facilities

events

November 20, 2024 - November 22, 2024

Updates in the Genetics and Epigenetics of Hematological Malignancies: From Knowledge to Applications

Josep Carreras Institute Symposium

IJC Auditorium + Online
Registration here

Symposium

April 19, 2024 (12:00)

“Fueling Cancer: Exploring the Role of Metabolism in Tumorigenesis”

Dr. Guadalupe Sabio

IJC Auditorium + Online
Registration here

Invited Lectures

May 07, 2024 (9:30)

Campus Can Ruti Core Facilities Infoday

IJC Auditorium + Online
Registration here

Campus events

May 24, 2024 (12:00)

“Actionable Genetic Signatures of Aggressive B-cell Lymphoma”

Prof. Björn Chapuy

IJC Auditorium + Online
Registration here

Distinguished Lectures

Latest Publications

10. Role of high dimensional technology in preeclampsia (omics in preeclampsia)

Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study

EASIX SCORE CORRELATES WITH ENDOTHELIAL DYSFUNCTION BIOMARKERS AND PREDICTS RISK OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC TRANSPLANTATION

Single-Cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Latest news

Vincenzo Calvanese: “I want to know what makes a stem cell… a stem cell”

April 11, 2024

Vincenzo Calvanese: “I want to know what makes a stem cell… a stem cell”

The last trick of p53: early 3D chromatin remodelling to trigger cellular stress response

April 05, 2024

The last trick of p53: early 3D chromatin remodelling to trigger cellular stress response

The Josep Carreras Leukaemia Research Institute is accredited as a Severo Ochoa Centre of Excellence

March 25, 2024

The Josep Carreras Leukaemia Research Institute is accredited as a Severo Ochoa Centre of Excellence

Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases

March 14, 2024

Researchers find the key to genome-modifying drugs sensitivity in malignant blood diseases

The Spanish Association Against Cancer selects five projects from the Josep Carreras Institute for its 2023 Research Grants

March 11, 2024

The Spanish Association Against Cancer selects five projects from the Josep Carreras Institute for its 2023 Research Grants

OneChain Immunotherapeutics receives support to advance a new promising CAR T therapy for a rare leukaemia with no therapeutic alternatives

March 04, 2024

OneChain Immunotherapeutics receives support to advance a new promising CAR T therapy for a rare leukaemia with no therapeutic alternatives

Awakening leukaemic stem cells to make them sensitive to chemotherapy

February 27, 2024

Awakening leukaemic stem cells to make them sensitive to chemotherapy

Locations

IJC Josep Trueta

Who we are, in data

438

4 programs

40 Research Groups

381 Researchers and technicians

57 Management staff

293 Women

144 Men

1 Others